264 related articles for article (PubMed ID: 36756616)
1. Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with
Varga A; Makszin L; Bufa A; Sipos D; Kása P; Pál S; Rosenstiel P; Sommer F; Kocsis B; Péterfi Z
Front Cell Infect Microbiol; 2023; 13():1041384. PubMed ID: 36756616
[TBL] [Abstract][Full Text] [Related]
2. How to Apply FMT More Effectively, Conveniently and Flexible - A Comparison of FMT Methods.
Varga A; Kocsis B; Sipos D; Kása P; Vigvári S; Pál S; Dembrovszky F; Farkas K; Péterfi Z
Front Cell Infect Microbiol; 2021; 11():657320. PubMed ID: 34150673
[TBL] [Abstract][Full Text] [Related]
3. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
4. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
[TBL] [Abstract][Full Text] [Related]
5. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
[TBL] [Abstract][Full Text] [Related]
6. Design and manufacture of a lyophilised faecal microbiota capsule formulation to GMP standards.
Zain NMM; Ter Linden D; Lilley AK; Royall PG; Tsoka S; Bruce KD; Mason AJ; Hatton GB; Allen E; Goldenberg SD; Forbes B
J Control Release; 2022 Oct; 350():324-331. PubMed ID: 35963468
[TBL] [Abstract][Full Text] [Related]
7. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: experience with lyophilized oral capsules.
Reigadas E; Bouza E; Olmedo M; Vázquez-Cuesta S; Villar-Gómara L; Alcalá L; Marín M; Rodríguez-Fernández S; Valerio M; Muñoz P
J Hosp Infect; 2020 Jun; 105(2):319-324. PubMed ID: 31883938
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
9. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy.
Jiang ZD; Ajami NJ; Petrosino JF; Jun G; Hanis CL; Shah M; Hochman L; Ankoma-Sey V; DuPont AW; Wong MC; Alexander A; Ke S; DuPont HL
Aliment Pharmacol Ther; 2017 Apr; 45(7):899-908. PubMed ID: 28220514
[TBL] [Abstract][Full Text] [Related]
11. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of Clostridioidesdifficile infection with single-donorfaecal microbiota transplantation capsules.
Cold F; Svensson CK; Christensen AH; Günther S; Petersen AM; Hansen LH; Helms M
Dan Med J; 2022 Jan; 69(2):. PubMed ID: 35088703
[TBL] [Abstract][Full Text] [Related]
13. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent
Svensson CK; Cold F; Ribberholt I; Zangenberg M; Mirsepasi-Lauridsen HC; Petersen AM; Helms M
Cells; 2022 Oct; 11(20):. PubMed ID: 36291139
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Bile Acid Composition Changes Following Faecal Microbiota Transplantation for Clostridioides difficile Infection in Children With and Without Underlying Inflammatory Bowel Disease.
Chen LA; Oliva-Hemker M; Radin A; Weidner M; O'Laughlin BD; Sears CL; Javitt NB; Hourigan SK
J Crohns Colitis; 2023 Aug; 17(8):1364-1368. PubMed ID: 36988432
[TBL] [Abstract][Full Text] [Related]
16. Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report.
Wei S; Jespersen ML; Baunwall SMD; Myers PN; Smith EM; Dahlerup JF; Rasmussen S; Nielsen HB; Licht TR; Bahl MI; Hvas CL
Microbiome; 2022 Nov; 10(1):193. PubMed ID: 36352460
[TBL] [Abstract][Full Text] [Related]
17. Faecal microbiota transplantation for
Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
[TBL] [Abstract][Full Text] [Related]
18. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
19. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
[TBL] [Abstract][Full Text] [Related]
20. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
